Feasibility and safety of dobutamine/atropine stress test after acute myocardial infarction. Experience on 235 patients;Fattibilita e sicurezza del test eco-dobutamina/atropina dopo infarto miocardico acuto. Esperienza su 235 pazienti

Minerva Cardioangiologica

Volumn 45, Issue 10, 1997, Pages 483-488

  Paventi, S ^a,b   Biferali, F ^a   Ciavatti, M ^a   Falcone, M ^a   Palamara, A ^a  

^a SANDRO PERTINI HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Dobutamine adverse effects; Dobutamine diagnostic use; Echocardiography methods; Myocardial infarction

Indexed keywords

ATROPINE; DOBUTAMINE; ANTIARRHYTHMIC AGENT; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART ARRHYTHMIA; HEART INFARCTION; HOSPITALIZATION; METHODOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

ACUTE DISEASE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ATROPINE; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0031282967     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tuttle RR, Mills J Dobutamine development of a new catecholamine to selectively increase cardiac contractility, Circ Res 1975;36:185-96.
2. Ruffolo RR jr, Spradlin TA, Pollock GD, Waddell JE, Murphy PJ Alpha and beta adrenergic effects of the stereoisomers of dobutamine J Pharmacol Exp Ther 1981,219:447-52.
3. Sawada SG, Segar DS, Ryan T, Mertes H, Foltz J. Echocardiographic detection of coronary artery disease during dobutamine infusion Circulation 1991,83:1605-14
4. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J et al. Symptoms, adverse effects and complications associated with dobutamine stress echocardiography Experience in 1118 patients. Circulation 1993;88:15-9
5. Poldermans D, Fioretti PM, Boersma E, Forster T, van Urk H, Cornel JH et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994;73.456-9.
6. Picano E, Mathias W jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study Lancet 1994;344:1190-2.
7. Furiasse JG, La Barre TR, Moran JF, Henkin RE, Scanlon PJ. Malignant ventricular arrhythmias during dobutamine Thallium stress testing Circulation 1985,72(Suppl III).III-424.
8. Foster T, Mc Neil AJ, Salustri A, Reijs AEM, El-Said EM, Roelandt JRTC et al. Simultaneous dobutamine stress echocardiography and Technetium 99-m-Isonitrile single-proton emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol 1993;21 1591-6.
9. La Canna G, Alfieri O, Giubbini R, Lanzarini L, Mussini A, Landi P. Echocardiography during infusion of dobutamine for identification of reversible disfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994,23:617-26
10. Fetiveau R, Lanzarini L, Poli A, Diotallevi P, Ferrario M, Mussini A et al. Effetti collaterali e sicurezza del test eco-dobutamina. Esperienza in 373 pazienti. G It Cardiol 1995;25:193-201.